Modulators of LXR
2 Assignments
0 Petitions
Accused Products
Abstract
Compounds of the invention, such as compounds of formula (I):
-
- where n, m, A, B, R1, R2, R3, R4 and R5 are defined herein, are useful as modulators of the activity of liver X receptors. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
186 Citations
34 Claims
-
1. A compound having the following formula (II):
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)
-
2. The compound of claim 1 wherein:
-
n is 0 or 1; m is 0 to 2; R1 is aralkyl or heteroarylalkyl; R2 is cyano; R3 is haloalkyl; R4 is halo, alkyl or haloalkyl; each R5 is independently selected from the group consisting of halo, nitro, alkyl, alkenyl, haloalkyl, heterocyclyl, heteroaryl, —
R7—
CN, —
R7—
N(R8)2, —
R7—
OR8, —
R7—
O—
R9—
C(O)OR8, —
R7—
C(O)R11, —
R7—
C(O)OR8, —
R7—
C(O)N(R8)2, —
R7—
C(O)N(R8)OR8, —
R7—
C(O)N(R8)N(R8)2, —
R7—
C(O)N(R8)—
R9—
C(O)OR8, —
R7—
C(S)N(R8)2, —
R7—
N(R8)C(O)OR10, —
R7—
S(O)tR8 (where t is 0 to
2) and —
R7—
S(O)2N(R8)2;R6 is —
OR7—
, a direct bond, a straight or branched alkenylene chain or a straight or branched alkynylene chain;each R7 is independently selected from a direct bond or a straight or branched alkylene chain; each R8 is independently selected from hydrogen, alkyl, alkenyl, haloalkyl, haloalkenyl, aryl, aralkyl, aralkenyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heteroarylalkyl; each R9 is a straight or branched alkylene chain optionally substituted by aryl or heteroaryl; R10 is alkyl, aryl, aralkyl or cycloalkylalkyl; and R11 is hydrogen, alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heterarylalkyl.
-
-
3. The compound of claim 2 wherein R6 is —
- OR7—
.
- OR7—
-
4. The compound of claim 3 wherein R1 is aralkyl optionally substituted with one or more substituents independently selected from alkyl, halo or haloalkyl.
-
5. The compound of claim 4 wherein
n is 0 or 1; -
m is 0 to 2; R2 is cyano; R3 is trifluoromethyl; R4 is methyl, 1-methylethyl or chloro; each R5 is independently selected from the group consisting of halo, alkyl, alkenyl or haloalkyl.
-
-
6. The compound of claim 5 wherein each R5 is independently selected from chloro, bromo, fluoro, methyl, ethyl, 1-methylethyl, 1,1-dimethylethyl, ethenyl or trifluoromethyl.
-
7. The compound of claim 6 selected from the group consisting of the following:
-
1-(2,4-Dimethyl-benzyl)-6-[4-(3-isopropyl-phenoxy)-3-methyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(4-tert-Butyl-phenoxy)-3-methyl-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(4-fluoro-phenoxy)-3-methyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(2,4-dimethyl-phenoxy)-3-methyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(2,5-dimethyl-phenoxy)-3-methyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(2,6-dimethyl-phenoxy)-3-methyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(2-Chloro-phenoxy)-3-methyl-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(3-Chloro-phenoxy)-3-methyl-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[3-methyl-4-(2-trifluoromethyl-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[3-methyl-4-(3-trifluoromethyl-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(3-Bromo-phenoxy)-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(4-Bromo-phenoxy)-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(3-Benzyloxy-phenoxy)-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(2,4-dimethyl-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(3,5-Bis-trifluoromethyl-phenoxy)-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-(4-Benzyloxy-phenyl)-1-(2,4-dichloro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dichloro-benzyl)-2-oxo-6-(4-phenoxy-phenyl)-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Difluoro-benzyl)-2-oxo-6-(4-phenoxy-phenyl)-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2-Chloro-4-fluoro-benzyl)-2-oxo-6-(4-phenoxy-phenyl)-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-(4-Benzyloxy-phenyl)-1-(2-chloro-4-fluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dichloro-benzyl)-2-oxo-4-pentafluoroethyl-6-(4-phenoxy-phenyl)-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-(3-isopropyl-4-phenoxy-phenyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-(3-isopropyl-4-o-tolyloxy-phenyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(2-ethyl-phenoxy)-3-isopropyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(2,5-dimethyl-phenoxy)-3-isopropyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(2,4-dimethyl-phenoxy)-3-isopropyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(3,4-dimethyl-phenoxy)-3-isopropyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-(3-isopropyl-4-m-tolyloxy-phenyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[3-isopropyl-4-(3-isopropyl-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[3-isopropyl-4-(4-isopropyl-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-(3-isopropyl-4-p-tolyloxy-phenyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(4-tert-Butyl-phenoxy)-3-isopropyl-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[3-isopropyl-4-(4-vinyl-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(4-ethyl-2-methyl-phenoxy)-3-methyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(4-ethyl-2-methyl-phenoxy)-3-isopropyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(2-ethyl-4-methyl-phenoxy)-3-methyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(2-ethyl-4-methyl-phenoxy)-3-isopropyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-(4-Benzyloxy-3-chloro-phenyl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[3-Chloro-4-(4-fluoro-phenoxy)-phenyl]-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; and 1-(2,4-Difluoro-benzyl)-6-[4-(4-fluoro-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile, or a pharmaceutically acceptable salt of any of the foregoing.
-
-
8. The compound of claim 4 wherein:
-
n is 0 or 1; m is 1 or 2; R2 is cyano; R3 is trifluoromethyl; R4 is methyl, 1-methylethyl or chloro; each R5 is independently selected from the group consisting of haloalkyl, —
R7—
CN, —
R7—
N(R8)2, —
R7—
OR8 and R7—
O—
R9—
C(O)OR8each R7 is independently selected from a direct bond or methylene chain; each R8 is independently selected from hydrogen, alkyl, aryl and aralkyl; and R9 is a methylene chain.
-
-
9. The compound of claim 8 selected from the group consisting of the following:
-
6-[4-(4-Dimethylamino-phenoxy)-3-methyl-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(4-methoxy-phenoxy)-3-methyl-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(3-Cyano-phenoxy)-3-methyl-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(4-Benzyloxy-phenoxy)-3-methyl-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(3-Benzyloxy-phenoxy)-3-methyl-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(3-Cyano-phenoxy)-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(4-Cyano-phenoxy)-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(4-Dimethylamino-phenoxy)-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(4-hydroxy-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(3-hydroxy-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(4-hexyloxy-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-{4-[4-(3-methyl-butoxy)-phenoxy]-phenyl}-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(3-hexyloxy-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-{4-[3-(3-methyl-butoxy)-phenoxy]-phenyl}-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; (3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-phenoxy)-acetic acid benzyl ester; (4-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-phenoxy)-acetic acid benzyl ester; 1-(2,4-Dimethyl-benzyl)-2-oxo-6-[4-(4-phenylamino-phenoxy)-phenyl]-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(4-Benzylamino-phenoxy)-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-[4-(3-hydroxymethyl-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(3-Benzyloxy-phenoxy)-3-isopropyl-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 6-[4-(4-Benzyloxy-phenoxy)-3-isopropyl-phenyl]-1-(2,4-dimethyl-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Difluoro-benzyl)-6-[4-(3-hydroxy-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Difluoro-benzyl)-6-[4-(4-hydroxy-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; and 6-[4-(3-Cyano-4-trifluoromethyl-phenoxy)-phenyl]-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile, or a pharmaceutically acceptable salt of any of the foregoing.
-
-
10. The compound of claim 4 wherein:
-
n is 0 or 1; m is 1 or 2; R2 is cyano; R3 is trifluoromethyl; R4 is methyl, 1-methylethyl or chloro; each R5 is independently selected from the group consisting of heteroaryl, —
R7—
OR8, —
R7—
C(O)R11, —
R7—
C(O)OR8, —
R7—
C(O)N(R8)2, —
R7—
C(O)N(R8)OR8, —
R7—
C(O)N(R8)N(R8)2, —
R7—
C(O)N(R8)—
R9—
C(O)OR8, —
R7—
C(S)N(R8)2 and —
R7—
S(O)tR8 (where t is 0 to
2);each R7 is independently selected from a direct bond or a straight or branched alkylene chain; each R8 is independently selected from hydrogen, alkyl, haloalkyl, aryl, aralkyl, aralkenyl, cycloalkyl or heterocyclyl optionally substituted with hydroxy; R9 is a straight or branched alkylene chain (optionally substituted by phenyl or imidazolyl); and R11 is hydrogen, alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heterarylalkyl.
-
-
11. The compound of claim 10 wherein:
-
m is 1 or 2; each R5 is independently selected from —
R7—
OR8, —
R7—
C(O)R11, —
R7—
C(O)OR8, —
R7—
C(O)N(R8)2, —
R7—
C(O)N(R8)OR8 or —
R7—
C(O)N(R8)N(R8)2;each R7 is independently selected from a direct bond or methylene; each R8 is independently selected from hydrogen, methyl, ethyl, 1,1-dimethylethyl, benzyl, 2-phenylethyl, cyclohexyl or piperidinyl optionally substituted by hydroxy; and R11 is hydrogen, alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heterarylalkyl.
-
-
12. The compound of claim 11 selected from the group consisting of the following:
-
4-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-2-methyl-phenoxy}-benzoic acid methyl ester; 3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-2-methyl-phenoxy}-benzoic acid methyl ester; 4-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoic acid; 3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-N-methyl-benzamide; 3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-N,N-dimethyl-benzamide; 1-(2,4-Dimethyl-benzyl)-2-oxo-6-{4-[3-(piperidine-1-carbonyl)-phenoxy]-phenyl}-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-{4-[3-(3-hydroxy-piperidine-1-carbonyl)-phenoxy]-phenyl}-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; N-Benzyl-3-{4-[5-cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzamide; 3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoic acid N′
-phenyl-hydrazide;3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-N-cyclopentyl-benzamide; 3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-N-methoxy-N-methyl-benzamide; 3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-N—
((S)-1-phenyl-ethyl)-benzamide;3-{4-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-N,N-dimethyl-benzamide; 3-Benzyloxy-5-{4-[5-cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoic acid methyl ester; 3-Benzyloxy-5-{4-[5-cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-N,N-dimethyl-benzamide; 3-{4-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-5-hydroxy-N,N-dimethyl-benzamide; 2-Benzyloxy-5-{4-[5-cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-N,N-dimethyl-benzamide; 5-{4-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-2-hydroxy-N,N-dimethyl-benzamide; 3-{4-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-N-methyl-benzamide; N-tert-Butyl-3-{4-[5-cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzamide; and 1-(2,4-Difluoro-benzyl)-2-oxo-6-{4-[3-(piperidine-1-carbonyl)-phenoxy]-phenyl}-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile, or a pharmaceutically acceptable salt of any of the foregoing.
-
-
13. The compound of claim 4 wherein:
-
n is 0 or 1; m is 1 or 2; R2 is cyano; R3 is trifluoromethyl; R4 is methyl, 1-methylethyl or chloro; each R5 is independently selected from the group consisting of heteroaryl, —
R7—
C(O)N(R8)—
R9—
C(O)OR8, —
R7—
C(S)N(R8)2 and —
R7—
S(O)tR8 (where t is 0 to
2);each R7 is independently selected from a direct bond or a straight or branched alkylene chain; each R8 is independently selected from hydrogen or alkyl, haloalkyl, aryl, aralkyl, aralkenyl, cycloalkyl or heterocyclyl; and R9 is a straight or branched alkylene chain (optionally substituted by phenyl or imidazolyl).
-
-
14. The compound of claim 13 wherein:
-
n is 0 or 1; m is 1; R2 is cyano; R3 is trifluoromethyl; R4 is chloro; R5 is —
R7—
C(O)N(R8)—
R9—
C(O)OR8;R7 is a direct bond; each R8 is independently hydrogen or alkyl; and R9 is a straight or branched alkylene chain optionally substituted by phenyl or imidazolyl.
-
-
15. The compound of claim 14 selected from the group consisting of the following:
-
(S)-2-(3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoylamino)-propionic acid methyl ester; (R)-2-(3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoylamino)-propionic acid methyl ester; (S)-2-(3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoylamino)-3-methyl-butyric acid methyl ester; (R)-2-(3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoylamino)-3-methyl-butyric acid methyl ester; (S)-2-(3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoylamino)-4-methyl-pentanoic acid methyl ester; (R)-2-(3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoylamino)-4-methyl-pentanoic acid methyl ester; (S)-2-(3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoylamino)-3-phenyl-propionic acid methyl ester; (R)-2-(3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoylamino)-3-phenyl-propionic acid methyl ester; (S)-2-(3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoylamino)-3-(1H-imidazol-4-yl)-propionic acid methyl ester; (R)-2-(3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoylamino)-3-(1H-imidazol-4-yl)-propionic acid methyl ester; (S)-(3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoylamino)-phenyl-acetic acid methyl ester; and (R)-(3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-benzoylamino)-phenyl-acetic acid methyl ester, or a pharmaceutically acceptable salt of any of the foregoing.
-
-
16. The compound of claim 13 wherein:
-
n is 0 or 1; m is 1; R2 is cyano; R3 is trifluoromethyl; R4 is methyl, 1-methylethyl or chloro; each R5 is independently selected from the group consisting of phthalimidyl, —
R7—
C(S)N(R8)2 and —
R7—
S(O)tR8 (where t is 0 or
2);each R7 is a direct bond; and each R8 is independently selected from hydrogen or alkyl.
-
-
17. The compound of claim 16 selected from the group consisting of the following:
-
1-(2,4-Dimethyl-benzyl)-6-[4-(4-methylsulfanyl-phenoxy)-phenyl]-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Dimethyl-benzyl)-6-{4-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-phenoxy]-phenyl}-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 3-{4-[5-Cyano-1-(2,4-dimethyl-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-phenoxy}-N,N-dimethyl-thiobenzamide; and 6-[3-Chloro-4-(4-methanesulfonyl-phenoxy)-phenyl]-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile, or a pharmaceutically acceptable salt of any of the foregoing.
-
-
18. The compound of claim 3 wherein R1 is heteroarylalkyl.
-
19. The compound of claim 18 wherein:
-
n is 0 or 1; m is 0-2; R1 is optionally substituted thiazol-5-ylmethyl; R2 is cyano; R3 is trifluoromethyl; R4 is methyl, 1-methylethyl or chloro; each R5 is independently selected from the group consisting of halo, alkyl, alkenyl or haloalkyl.
-
-
20. The compound of claim 19, i.e., namely 1-(2,5-Diethyl-thiazol-4-ylmethyl)-2-oxo-6-(4-phenoxy-phenyl)-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile, or a pharmaceutically acceptable salt thereof.
-
21. The compound of claim 2 wherein:
-
R1 is aralkyl optionally substituted with one or more substituents independently selected from alkyl, halo or haloalkyl; each R5 is independently selected from the group consisting of halo, nitro, alkyl, alkenyl, haloalkyl, —
R7—
CN, —
R7—
N(R8)2, —
R7—
OR8, —
R7—
C(O)R11, —
R7—
C(O)OR8, —
R7—
C(O)N(R8)2, —
R7—
N(R8)C(O)OR10, —
R7—
S(O)tR8 (where t is 0 to
2) and —
R7—
S(O)2N(R8)2;R6 is a direct bond, a straight or branched alkenylene chain or a straight or branched alkynylene chain; each R7 is independently selected from a direct bond or a straight or branched alkylene chain; each R8 is independently selected from hydrogen, alkyl, cycloalkyl, cycloalkylalkyl or heterocyclyl; each R9 is a straight or branched alkylene chain optionally substituted by aryl or heteroaryl; R10 is alkyl, aryl, aralkyl or cycloalkylalkyl; and R11 is hydrogen, alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heterarylalkyl.
-
-
22. The compound of claim 21 wherein:
-
n is 0; m is 1 or 2; R1 is benzyl optionally substituted with one or more substituents independently selected from alkyl, halo or haloalkyl; R2 is cyano; R3 is trifluoromethyl; each R5 is independently selected from the group consisting of alkyl, trifluoromethyl, —
R7—
OR8 and R7—
S(O)tR8 (where t is 0 to
2);R6 is a direct bond; R7 is a direct bond; R8 is hydrogen or alkyl; and R9 is a straight or branched alkylene chain.
-
-
23. The compound of claim 22 selected from the group consisting of the following:
-
1-(2,4-Difluoro-benzyl)-6-(4′
-methanesulfonyl-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(4′
-methanesulfonyl-biphenyl-4-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(4′
-ethylsulfanyl-3′
-trifluoromethyl-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(4′
-ethanesulfonyl-3′
-trifluoromethyl-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(4′
-methylsulfanyl-3′
-trifluoromethyl-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(5′
-methylsulfanyl-3′
-trifluoromethyl-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(4′
-methylsulfanyl-3′
-trifluoromethyl-biphenyl-4-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(5′
-methylsulfanyl-3′
-trifluoromethyl-biphenyl-4-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(4′
-methanesulfonyl-3′
-trifluoromethyl-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(4′
-methanesulfonyl-3′
-trifluoromethyl-biphenyl-4-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(3′
-methanesulfonyl-5′
-trifluoromethyl-biphenyl-4-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(3′
-ethanesulfonyl-5′
-trifluoromethyl-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-[3′
-(propane-2-sulfonyl)-5′
-trifluoromethyl-biphenyl-3-yl]-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(4′
-ethoxy-3′
-methanesulfonyl-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-[5′
-(propane-1-sulfinyl)-3′
-trifluoromethyl-biphenyl-3-yl]-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-[5′
-(Butane-1-sulfinyl)-3′
-trifluoromethyl-biphenyl-3-yl]-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-(5′
-phenylmethanesulfinyl-3′
-trifluoromethyl-biphenyl-3-yl)-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-(5′
-Cyclopropylmethanesulfinyl-3′
-trifluoromethyl-biphenyl-3-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-[5′
-(propane-1-sulfinyl)-3′
-trifluoromethyl-biphenyl-4-yl]-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-[5′
-(Butane-1-sulfinyl)-3′
-trifluoromethyl-biphenyl-4-yl]-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-(5′
-phenylmethanesulfinyl-3′
-trifluoromethyl-biphenyl-4-yl)-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-(5′
-Cyclopropylmethanesulfinyl-3′
-trifluoromethyl-biphenyl-4-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(5′
-ethanesulfinyl-3′
-trifluoromethyl-biphenyl-4-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-[3′
-(propane-2-sulfinyl)-5′
-trifluoromethyl-biphenyl-4-yl]-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-[3′
-(propane-1-sulfonyl)-5′
-trifluoromethyl-biphenyl-3-yl]-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-[3′
-(propane-1-sulfonyl)-5′
-trifluoromethyl-biphenyl-4-yl]-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-[3′
-(Butane-1-sulfonyl)-5′
-trifluoromethyl-biphenyl-3-yl]-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-[3′
-(Butane-1-sulfonyl)-5′
-trifluoromethyl-biphenyl-4-yl]-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-(3′
-phenylmethanesulfonyl-5′
-trifluoromethyl-biphenyl-3-yl)-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-(3′
-phenylmethanesulfonyl-5′
-trifluoromethyl-biphenyl-4-yl)-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-(3′
-Cyclopropylmethanesulfonyl-5′
-trifluoromethyl-biphenyl-3-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-(3′
-Cyclopropylmethanesulfonyl-5′
-trifluoromethyl-biphenyl-4-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(3′
-ethanesulfonyl-5′
-trifluoromethyl-biphenyl-4-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-[3′
-(propane-2-sulfonyl)-5′
-trifluoromethyl-biphenyl-4-yl]-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(5′
-isopropyl-3′
-methanesulfonyl-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(5′
-ethyl-3′
-methanesulfonyl-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(3′
-ethanesulfonyl-5′
-isopropyl-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; and1-(2,4-Difluoro-benzyl)-6-(3′
-methanesulfonyl-5′
-trifluoromethyl-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile,or a pharmaceutically acceptable salt of any of the foregoing.
-
-
24. The compound of claim 21 wherein:
-
n is 0; m is 1 or 2; R1 is benzyl optionally substituted with one or more substituents independently selected from alkyl, halo or haloalkyl; R2 is cyano; R3 is trifluoromethyl; each R5 is independently selected from the group consisting of alkyl, —
R7—
C(O)R11, —
R7—
C(O)OR8 or —
R7—
C(O)N(R8)2;R6 is a direct bond; each R7 is a direct bond; each R8 is independently hydrogen, alkyl, aryl or aralkyl; and R11 is hydrogen, alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, pyrrolidinyl or piperidinyl.
-
-
25. The compound of claim 24 selected from the group consisting of the following:
-
6-(3′
-Acetyl-biphenyl-3-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-(4′
-Acetyl-biphenyl-3-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;3′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-3-carboxylic acid amide;3′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-4-carboxylic acid amide;3′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-3-carboxylic acid dimethylamide;3′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-4-carboxylic acid dimethylamide;1-(2,4-Difluoro-benzyl)-2-oxo-6-[3′
-(pyrrolidine-1-carbonyl)-biphenyl-3-yl]-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-[4′
-(piperidine-1-carbonyl)-biphenyl-3-yl]-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;3′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-3-carboxylic acid ethylamide;3′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-4-carboxylic acid methylamide;3′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-4-carboxylic acid phenylamide;3′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-4-carboxylic acid benzylamide;{3′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-3-yl}-acetic acid;{4′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-3-yl}-acetic acid;{3′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-4-yl}-acetic acid;{4′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-4-yl}-acetic acid;{3-Chloro-3′
-[5-cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-4-yl}-acetic acid methyl ester; and{3-Chloro-3′
-[5-cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-biphenyl-4-yl}-acetic acid,or a pharmaceutically acceptable salt of any of the foregoing.
-
-
26. The compound of claim 21 wherein:
-
n is 0; m is 0-2; R2 is cyano; R3 is trifluoromethyl; each R5 is independently selected from the group consisting of halo, alkyl, alkenyl, haloalkyl or —
R7—
OR8;R6 is a direct bond, a straight or branched alkenylene chain or a straight or branched alkynylene chain; R7 is a direct bond; and R8 is hydrogen or alkyl.
-
-
27. The compound of claim 26 selected from the group consisting of the following:
-
6-(3′
,5′
-Bis-trifluoromethyl-biphenyl-3-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-(3′
,5′
-Bis-trifluoromethyl-biphenyl-4-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-(3′
-Chloro-4′
-ethoxy-biphenyl-3-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(3′
,4′
-dimethoxy-biphenyl-4-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-(3′
-Chloro-4′
-ethoxy-biphenyl-4-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-2-oxo-6-(3-phenylethynyl-phenyl)-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Difluoro-benzyl)-2-oxo-6-(4-phenylethynyl-phenyl)-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; 1-(2,4-Difluoro-benzyl)-2-oxo-6-[3-((E)-styryl)-phenyl]-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; and 1-(2,4-Difluoro-benzyl)-2-oxo-6-[4-((E)-styryl)-phenyl]-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile, or a pharmaceutically acceptable salt of any of the foregoing.
-
-
28. The compound of claim 21 wherein:
-
n is 0; m is 1 or 2; R2 is cyano; R3 is trifluoromethyl; each R5 is independently selected from the group consisting of nitro, —
R7—
N(R8)2, —
R7—
OR8 or —
R7—
N(R8)C(O)OR10;R6 is a direct bond; each R7 is a direct bond; each R8 is independently selected from hydrogen or alkyl; and R10 is alkyl.
-
-
29. The compound of claim 28 selected from the group consisting of the following:
-
6-(3′
-Amino-biphenyl-3-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;1-(2,4-Difluoro-benzyl)-6-(4′
-ethoxy-3′
-nitro-biphenyl-3-yl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile;6-(3′
-Amino-4′
-ethoxy-biphenyl-3-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile; and{3′
-[5-Cyano-1-(2,4-difluoro-benzyl)-6-oxo-4-trifluoromethyl-1,6-dihydro-pyridin-2-yl]-4-ethoxy-biphenyl-3-yl}-carbamic acid tert-butyl ester,or a pharmaceutically acceptable salt of any of the foregoing.
-
-
30. A method of reducing cholesterol levels in a subject in need thereof, comprising administering an effective amount of a compound of claim 1, or a pharmaceutically acceptable salt thereof.
-
31. A method of increasing cholesterol efflux from cells of a subject, comprising administering an effective amount of a compound of claim 1, or a pharmaceutically acceptable salt thereof.
-
32. A method of increasing the expression of ATP-Binding Cassette (ABC1) in the cells of a subject, comprising administering an effective amount of a compound of claim 1, or a pharmaceutically acceptable salt thereof.
-
33. A method of reducing cholesterol levels in a subject in need thereof, comprising administering an effective amount of a compound of claim 1.
-
34. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of claim 1.
-
2. The compound of claim 1 wherein:
Specification
- Resources
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeExelixis Incorporated
-
Original AssigneeExelixis Incorporated
-
InventorsWang, Haixia, Stevens, William C. Jr., Schweiger, Edwin J., Lu, Shao Po, Xie, Yinong, Johnson, Alan T., Bayne, Christopher D., Mohan, Raju, Nyman, Michael C.
-
Primary Examiner(s)NOLAN, JASON MICHAEL
-
Application NumberUS12/337,591Publication NumberTime in Patent Office993 DaysField of Search546/286, 546/290, 546/301, 546/302, 514/345US Class Current514/345CPC Class CodesA61P 1/16 for liver or gallbladder di...A61P 17/00 Drugs for dermatological di...A61P 17/02 for treating wounds, ulcers...A61P 17/10 Anti-acne agentsA61P 25/00 Drugs for disorders of the ...A61P 25/16 Anti-Parkinson drugsA61P 25/28 for treating neurodegenerat...A61P 29/00 Non-central analgesic, anti...A61P 3/00 Drugs for disorders of the ...A61P 3/04 Anorexiants; Antiobesity ag...A61P 3/06 AntihyperlipidemicsA61P 3/10 for hyperglycaemia, e.g. an...A61P 35/00 Antineoplastic agentsA61P 37/02 ImmunomodulatorsA61P 43/00 Drugs for specific purposes...A61P 9/00 Drugs for disorders of the ...A61P 9/10 for treating ischaemic or a...C07D 213/84 NitrilesC07D 213/85 in position 3C07D 401/04 directly linked by a ring-m...C07D 401/06 : linked by a carbon chain co...C07D 401/10 : linked by a carbon chain co...C07D 401/12 : linked by a chain containin...C07D 401/14 : containing three or more he...C07D 405/04 : directly linked by a ring-m...C07D 405/06 : linked by a carbon chain co...C07D 405/12 : linked by a chain containin...C07D 405/14 : containing three or more he...C07D 409/04 : directly linked by a ring-m...C07D 409/06 : linked by a carbon chain co...C07D 409/14 : containing three or more he...C07D 413/06 : linked by a carbon chain co...C07D 417/04 : directly linked by a ring-m...C07D 417/06 : linked by a carbon chain co...C07D 417/12 : linked by a chain containin...